Publisher
Springer International Publishing
Reference61 articles.
1. Associated Press. (2014, April 6). Divide over HIV prevention drug Truvada persists. USA Today. Retrieved May 8, 2020, from https://www.usatoday.com/story/news/nation/2014/04/06/gay-men-divided-over-use-of-hiv-prevention-drug/7390879/.
2. Auerbach, J. D., & Hoppe, T. A. (2015). Beyond “getting drugs into bodies”: Social science perspectives on pre-exposure prophylaxis for HIV. Journal of the International AIDS Society, 18(4S3), 19983. https://doi.org/10.7448/IAS.18.4.19983.
3. Baeten, J. M., Donnell, D., Ndase, P., Mugo, N. R., Campbell, J. D., Wangisi, J., et al. (2012). Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. New England Journal of Medicine, 367(5), 399–410. https://doi.org/10.1056/Nejmoa1108524.
4. Calabrese, S. K., & Underhill, K. (2015). How stigma surrounding the use of HIV preexposure prophylaxis undermines prevention and pleasure: A call to destigmatize “Truvada whores”. American Journal of Public Health, 105(10), 1960–1964. https://doi.org/10.2105/AJPH.2015.302816.
5. Camlin, C. S., Koss, C. A., Getahun, M., Owino, L., Itiakorit, H., Akatukwasa, C., et al. (2020). Understanding demand for PrEP and early experiences of PrEP use among young adults in rural Kenya and Uganda: A qualitative study. AIDS and Behavior., 24(7), 2149–2162. https://doi.org/10.1007/s10461-020-02780-x.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献